Why the study?
Does exenatide reduce reperfusion injury and increase myocardial salvage in patients with STEMI undergoing pPCI?
Does exenatide reduce reperfusion injury and increase myocardial salvage in patients with STEMI undergoing pPCI?
Exenatide administered during primary PCI for STEMI may increase myocardial salvage and reduce reperfusion injury.
Supports adjunctive exenatide during STEMI pPCI; extends GLP-1 agonist evidence to reperfusion injury.
In patients with STEMI undergoing pPCI, administration of exenatide at the time of reperfusion increases myocardial salvage.
No takes yet. Share an insight, caveat, or question.
Lønborg et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: